Before You Invest Your Money

(Reuters) – CME Group Inc.’s overall growth is “absolutely not” dependent on its over-the-counter clearing venture, the head of the world’s largest derivatives exchange operator said on Thursday.Chicago-based CME has for nearly a year plotted to clear OTC-traded credit default swaps.OTC clearing is a “very compelling and significant growth opportunity for us, but I reckon it’s additive to the growth that I reckon we can achieve through these other things,” CEO Craig Donohue told investors.He said there is a “global expanding pie in derivatives,” adding that markets in North America and Europe are honestly mature while those in emerging markets are relatively immature.Kim Taylor, a CME managing director, added at the investor meeting that the company expects its European clearinghouse for CDS and other products to get British Financial Services Authority approval by about year’s end.